CDISC Standards Webinar Latest Updates and Additions 31 Jan 2013

Size: px
Start display at page:

Download "CDISC Standards Webinar Latest Updates and Additions 31 Jan 2013"

Transcription

1 CDISC Standards Webinar Latest Updates and Additions 31 Jan 2013

2 CDASH-SAE Domains CDISC CDASH SAE Team Update Rhonda Facile, CDISC Gary Walker, Quintiles CDISC

3 Agenda Background Mapping CDASH to E2B New Domains and Variables Timeline to publication Acknowledgements CDISC

4 Background The project started in 2010 Initiative sponsors: Barry Burnstead, Rhonda Facile Initial goal was to identify and describe the E2B fields that are collected at investigational sites. CDASH-E2B team officially formed CDISC

5 CDASH-E2B: Why? Reporting serious adverse events (SAEs) to regulatory bodies in a timely manner during the course of a clinical study is critical for Sponsors. However, in most cases, clinical data is not captured in line with the E2B industry safety standard, leading to a disconnect between clinical and safety databases. CDASH being the first standard applied to clinical data at point of capture needs to take account of all data requirements and destinations. CDISC

6 Our Goals To eliminate duplication of data collection enter data once, use when and where needed To provide the needed (and standardised) metadata that will assist and support drug safety in meeting regulatory reporting requirements CDISC

7 Mapping E2B to CDASH fields E2B R2 vs. CDASH 1.1 CDISC 2013

8 Gap Analysis A total of 235 E2B fields have been identified. 150 fields are not typically collected at site or do not have a CDASH identity 16 fields could/should be known or collected eg, causality assessment, reporter comments, country where the event occurred 85 fields are collected at site 68 fields already have CDASH identity 19 fields need a CDASH identity developed primarily regarding Parent and Death areas CDISC 2013

9 New Domains and Variables New CDASH identities recommended for the 35 identified gap fields Additional 15 identified during the F2F Meeting New SAE CDASH domain recommended SAE Addendum to CDASH being drafted Fields currently excluded from the CDASH-E2B mapping will be reviewed in future versions CDISC 2013

10 CDASH Data Elements DM, CM, MH, etc. CRF Domains data Investigator provides information through a single interface. ( combo form, linked forms, conditional forms) CDASH Data Elements: AE Domain AE CRF Data SAE Domain SAE Form Data All relevant clinical and related information including patient characteristics, therapy details, medical history, clinical course of the event, laboratory evidence and any other information that supports or refutes causality. Research Database Sponsor Safety Database Submit study data in SDTM format to regulators as needed. Report in E2B format to Health Authorities and other recipients in required timeframe

11 Examples of SAE domain data not already collected in CDASH CDASH SAE-specific variables SAERPTRFNM (SAE reporter s family name) ICSRID (Sender s safety case report unique ID) Subject data that could map to SDTM domains AUCDTH (DDORRES when DDTEST= Autopsy determined cause of death ) AUPERF (PROCCUR when PRTERM= Autopsy ) Data for Associated Persons that could map to SDTM domains APDM.AGE (APDM.AGE when DMRELSUB = Father, Biological ) APMH.MHTERM (APMH.MHTERM when MHRELSUM = Father, Biological ) CDISC

12 TENTATIVE TIMELINE TO PUBLICATION Submit to SRC for approval to post for public comment (February) Public review (March) Submit to SRC for approval to publish (April) Testing Initial Consensus Version TLC Review Harmonized Version OK CDISC Internal Review OK Reviewed Version Public Review Released (Production) Version (1.0) comments addressed by team SRC Review (For approval to post for public review) CDISC

13 CDASH-E2B Team Name Region Affiliation Address Gary Walker US Quintiles Barry Burnstead EU Select CRO Lauren Shinaberry EU Business & Decision Life Sciences Sonia Araujo EU Medidata Solutions Sean Neak EU Medidata Solutions Roland Franke EU PRA International Tracy Sanders US Foresight Group Ling Chin, MD, MPH US Consultant, GCP Clinical Trials Monica Mattson US Celgene Shannon Labout US CDISC Rhonda Facile US CDISC CDISC 2013

14 Questions Rhonda Facile Gary Walker CDISC

15 CDISC Online Training Saad Yousef, CDISC 15

16 Online Courses coming soon! Courses split into modules Technical and Therapeutic Area courses will be offered TA courses offered online only Technical courses still offered via public and private training First few modules to be available in early February. 16

17 How to sign up? Each registrant must create account by going to Same discounts available for GOLD (20%) and PLATINUM (40%) members. Discount codes are case sensitive. Each course contains an exam. Certificates available for passing candidates (automatic). 17

18 Advantages/Disadvantages Advantages Take courses from comfort of own office/home Self-paced Automatic certificate after test successfully passed Disadvantages No opportunity for discussion or to ask questions to an instructor Still have option of signing up for public and private courses. Click here for more info. No opportunity to network with others had you registered for public course offering. Click here for public course offering. 18

19 Questions? Please start sending in questions pertaining to CDASH-SAE or CDISC Online Training. 19

20 CDISC Education and Communications Updates Presented by: Saad Yousef, CDISC, Associate of Education and Operations 20

21 Read the Latest CDISC News Join our list Read our monthly e-newsletter See the CDISC home page: for all current events Read our Blogs: Follow us on social media! 21

22 What s New on the CDISC Website Subscribe to RSS Feeds Clear and easy display of the CDISC Standards and Innovations 22

23 What s New on the CDISC Website Rotating Banner at the bottom of the Home page and the Newsletter page to value our Platinum Members

24 Inaugural Asia-Pacific Interchange

25 Interchange Details Asia-Pacific Interchange in Singapore, Feb 2013 Deadline to register is 8 Feb 2013 Sponsorship opportunities available Education courses offered: ADaM, CDASH, Controlled Terminology, and SDTM 25

26 CDISC European Interchange

27 Interchange Details Europe Interchange in Germany, April 2013 Registration is now open Sponsorship opportunities available Education courses offered: ADaM, BRIDG Deep Dive, CDASH, Controlled Terminology, ODM, and SDTM 27

28 Other Public Education Opportunities Morrisville, NC from February 2013 South San Francisco, CA from 5-8 March 2013 St. Louis, MO from May 2013 Cambridge, MA on 17 July 2013 Full schedule and registration at Early registration discounts available for select public training events. Please click on the above link to access event registration details. 28

29 CDISC In-House Education Schedule in-house authorized CDISC education for your company - designed to meet your CDISC education needs. For more information: Visit our website or fill out private education request form found here (form can also be found at above webpage). 29

30 CDISC Authorized Instructors Find out who our instructors are at

31 Upcoming CDISC Webinars Watch for more CDISC Team Updates and other topics in our Webinar Series in the coming months CDISC Webinar schedule published at: Next webinar is scheduled for 7 March Visit the CDISC website (link above) for info on next year s webinars. 31

32 Get Involved! Become a CDISC Member Participate in Public Reviews Attend the Interchanges and authorized training Be a key collaborator Adopt the standards ask partners to do so Spread the word Volunteer For more information about CDISC please visit our website: 32

33 Any more questions? Thank you for attending this webinar. CDISC s vision is to: Inform Patient Care & Safety Through Higher Quality Medical Research 33

PROGRAM INTERCHANGE Japan

PROGRAM INTERCHANGE Japan A collaborative event to share progress, implementation experiences, and strategic ideas on worldwide data interchange standards for medical research. PROGRAM INTERCHANGE Japan 20-23 July 2010 Toshi Center

More information

PDUFA IV Information Technology Plan. Armando Oliva, M.D. Deputy Director for Bioinformatics Office of Critical Path Programs FDA

PDUFA IV Information Technology Plan. Armando Oliva, M.D. Deputy Director for Bioinformatics Office of Critical Path Programs FDA PDUFA IV Information Technology Plan Armando Oliva, M.D. Deputy Director for Bioinformatics Office of Critical Path Programs FDA Outline What is the PDUFA IV IT Plan? What does it say? How can CDISC and

More information

Site-Less CRO Model and esource: Framework for Action

Site-Less CRO Model and esource: Framework for Action Site-Less CRO Model and esource: Framework for Action Joe Martinez, RPh, PDE, PPC Princeton, NJ In-home and site-less clinical trials: changing the landscape How to test drugs, devices and procedures better

More information

Beijing esubmission Packages

Beijing esubmission Packages Single Day Event Beijing esubmission Packages 8th July 2016 Park Plaza Beijing Science Park Beijing 2016 PhUSE Single Day Event 1 Your guide to the day Introduction Agenda Time Title and Speaker 09:00

More information

New European Union Clinical Trial Regulations

New European Union Clinical Trial Regulations New European Union Clinical Trial Regulations Incorporate Monitoring and Safety Reporting Techniques into U.S. and EU Clinical Trial SOPs Anita K. Murthy Deputy Director, Global Regulatory Affairs Bayer

More information

Introduction to China CDISC Coordinating Committee (C3C) February 2014

Introduction to China CDISC Coordinating Committee (C3C) February 2014 Introduction to China CDISC Coordinating Committee (C3C) February 2014 Outline Regulatory history of study data in China CDISC application and history in China China CDISC coordinating committee (C3C)

More information

Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare

Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare Notification number: 0427-1 April 27, 2015 To: Prefectural Health Department (Bureau) Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau, Ministry of Health, Labour and Welfare Notification

More information

Clinical Research Professionals

Clinical Research Professionals Training & Resources for Clinical Research Professionals Course & Publications Catalog January July 2016 In-Person and Web-Based Training Courses, Customized Training, elearning and Publications for Clinical

More information

CDISC Asia-Pacific/Japan Interchange CDISC Standards: Transcending Geographic Lines for the Betterment of Clinical Research

CDISC Asia-Pacific/Japan Interchange CDISC Standards: Transcending Geographic Lines for the Betterment of Clinical Research CDISC Asia-Pacific/Japan Interchange CDISC Standards: Transcending Geographic Lines for the Betterment of Clinical Research 28 July - 01 August 2014 AP Tokyo Yaesu-Dori KPP Yaesu Building Tokyo, Japan

More information

Why do we need an addendum to ICH E6?

Why do we need an addendum to ICH E6? Addendum to ICH E6 Hideaki Ui, Ph.D. Inspection Director Office of Non-clinical and Clinical Compliance Pharmaceuticals and Medical Devices Agency, Japan Disclaimer The views and opinions expressed in

More information

2014 CDISC International Interchange Conference Program

2014 CDISC International Interchange Conference Program 2014 CDISC International Interchange Conference Program Embracing a Changing Landscape Standards to Connect Research and Patient Care B e t h e s d a N o r t h M a r r i o t t H o t e l a n d C o n f e

More information

Now We are Getting to the Hard Parts: An Analysis Files Perspective

Now We are Getting to the Hard Parts: An Analysis Files Perspective Now We are Getting to the Hard Parts: An Analysis Files Perspective Steve Wilson Director, CDER/OTS/OB/DBIII 2010 CDISC Interchange Renaissance Hotel, Baltimore, MD November 3-4, 2010 Disclaimer Views

More information

Targeted technology and data management solutions for observational studies

Targeted technology and data management solutions for observational studies Targeted technology and data management solutions for observational studies August 18th 2016 Zia Haque Arshad Mohammed Copyright 2016 Quintiles Your Presenters Zia Haque Senior Director of Data Management,

More information

Japanese submission/approval processes from programming perspective Ryan Hara, Novartis Pharma AG, Basel, Switzerland

Japanese submission/approval processes from programming perspective Ryan Hara, Novartis Pharma AG, Basel, Switzerland PharmaSUG 2015 - Paper SS02 Japanese submission/approval processes from programming perspective Ryan Hara, Novartis Pharma AG, Basel, Switzerland The opinions expressed in this paper and on the following

More information

EV Reporting process for users: Creating and sending ICSRs using EVWEB part II

EV Reporting process for users: Creating and sending ICSRs using EVWEB part II EV Reporting process for users: Creating and sending ICSRs using EVWEB part II Training Module EV-M3e An agency of the European Union Content Summary Introduction Nullifications and Amendments Creating

More information

Commission Guidelines for the implementation of the Clinical Trials Regulation NTA Ethics Oslo

Commission Guidelines for the implementation of the Clinical Trials Regulation NTA Ethics Oslo Commission Guidelines for the implementation of the Clinical Trials Regulation NTA Ethics 30.1.2017 Oslo 3.2.2017 O. Konttinen 1 Background Based on directive 2001/20/EC of the clinical trials on medicinal

More information

General Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility

General Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility General Administration GA 102.01 STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility Approval: Nancy Paris, MS, FACHE President and CEO (17 July 2014) (Signature and

More information

Introduction To Medpace & Clinical Research Overview

Introduction To Medpace & Clinical Research Overview Introduction To Medpace & Clinical Research Overview Medpace Overview o o o o o We are a Contract Research Organization (CRO) Work closely with biotech, pharma, and device companies Full Service Model

More information

Keele Clinical Trials Unit

Keele Clinical Trials Unit Keele Clinical Trials Unit Standard Operating Procedure (SOP) Summary Box Title Safety Reporting and Pharmacovigilance SOP Index Number SOP 20 Version 4.0 Approval Date 31-Jan-2017 Effective Date 14-Feb-2017

More information

Study Start-Up SS STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV)

Study Start-Up SS STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV) Replaces previous version 203.01: 01 July 2014 Study Start-Up SS 203.01 STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV) Approval: Nancy Paris, MS, FACHE President and CEO 24 May 2017 (Signature

More information

Paper PO 53. Reporting of treatment emergent adverse events based on pooled data Analysis or Country Specific Submissions: A case study

Paper PO 53. Reporting of treatment emergent adverse events based on pooled data Analysis or Country Specific Submissions: A case study Paper PO 53 Reporting of treatment emergent adverse events based on pooled data Analysis or Country Specific Submissions: A case study Sheetal Shiralkar- Independent Consultant. Plainsboro-NJ Often sponsor

More information

STEM Academy Project Based Learning

STEM Academy Project Based Learning STEM Academy Project Based Learning LIGHT Awards Program 2015 Laura Beaudrow 1234 Main Street San Francisco, CA 94105 info@lightawards.org Printed On: 7 October 2014 LIGHT Awards Program 2015 1 Application

More information

TORA User Guide. How to Submit an Application on TORA for Institutional Approval

TORA User Guide. How to Submit an Application on TORA for Institutional Approval TORA User Guide How to Submit an Application on TORA for Institutional Approval Contents User Guide Objectives... 1 Logging in to TORA... 1 Menu Pages View... 3 Completing the Form... 3 Tab 1: Project

More information

1. Introduction, purpose of this Standard Operating Procedure (SOP)

1. Introduction, purpose of this Standard Operating Procedure (SOP) Details Document Type Document name Ref # Version Effective from Review date Owner Prepared by Reviewed by Approved by Superseded documents Relevant regulations/legislation/guidelines/reference Standard

More information

1. Introduction, purpose of this Standard Operating Procedure (SOP)

1. Introduction, purpose of this Standard Operating Procedure (SOP) SOP-CTN-001- Clinical Trial Network - General Organisation and Principles European Society of Anaesthesiology Details Document Type Document name Ref # Version Effective from Review date Owner Prepared

More information

MassHealth Provider Billing and Services Updates & Upcoming Initiatives. Massachusetts Health Care Training Forum July 2011

MassHealth Provider Billing and Services Updates & Upcoming Initiatives. Massachusetts Health Care Training Forum July 2011 MassHealth Provider Billing and Services Updates & Upcoming Initiatives Massachusetts Health Care Training Forum July 2011 Agenda I. MassHealth Updates/Resources & Upcoming MassHealth Initiatives II. Paper

More information

Global Village / Stand Submission form

Global Village / Stand Submission form WE SHOWCASE The European Development Days 2018 5-6 June 2018 Brussels, Belgium eudevdays.eu Global Village / Stand Submission form International Cooperation and Development STEP 1 GENERAL The EDD Global

More information

Sponsor and Exhibitor Prospectus

Sponsor and Exhibitor Prospectus Sponsor and Ehibitor Prospectus March 14-16, 2017 Marriott Shanghai City Center Shanghai, China MBA Career Services & Employer Alliance Setting the Standard. Connecting the Industry. Thank you for your

More information

Study Management SM STANDARD OPERATING PROCEDURE FOR Adverse Event Reporting

Study Management SM STANDARD OPERATING PROCEDURE FOR Adverse Event Reporting Study Management SM 306.00 STANDARD OPERATING PROCEDURE FOR Adverse Event Reporting Approval: Nancy Paris, MS, FACHE President and CEO 24 May 2017 (Signature and Date) Approval: Frederick M. Schnell, MD,

More information

S t r e n g t h t h r o u g h C o l l a b o r a t i o n

S t r e n g t h t h r o u g h C o l l a b o r a t i o n THE INTERCHANGE SCHEDULE S t r e n g t h t h r o u g h C o l l a b o r a t i o n MONDAY 4 MAY 2015 09:00 17:30 FDA Reviewer Session 09:00 12:30 Controlled Terminology Course 09:00 17:30 CDASH Implementation

More information

Addendum to ICH E6 (R2)

Addendum to ICH E6 (R2) Addendum to ICH E6 (R2) Stephanie Shapley (US FDA) - Rapporteur Dr. Fergus Sweeney (EMA) - Regulatory Chair Date: December 15, 2015 International Council for Harmonisation of Technical Requirements for

More information

Annex 1 EXHIBITION & SPONSORSHIP PLANNER. 17 May 2018 Crowne Plaza Dublin Blanchardstown Dublin Ireland. Revision of the EU GMP Guideline

Annex 1 EXHIBITION & SPONSORSHIP PLANNER. 17 May 2018 Crowne Plaza Dublin Blanchardstown Dublin Ireland. Revision of the EU GMP Guideline PDA Europe Workshop, Exhibition, Education The Parenteral Drug Association presents: Annex 1 Revision of the EU GMP Guideline EXHIBITION & SPONSORSHIP PLANNER pda.org/eu/annex1_dublin 17 May 2018 Crowne

More information

Feedback from our EARMA 2015 workshop: Research Funding Identification, Engagement and Dissemination Strategies

Feedback from our EARMA 2015 workshop: Research Funding Identification, Engagement and Dissemination Strategies Idox Feedback from our EARMA 2015 workshop: Research Funding Identification, Engagement and Dissemination Strategies June July 2015 rc.research@idoxgroup.com Contents Introduction... 2 The University of

More information

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Safety Reporting in CTIMPs and ATMPs SOP number: TM 003 SOP category: Trial Management Version number: 03 Version date:

More information

Care Partners Monthly Webinar #3

Care Partners Monthly Webinar #3 Care Partners Monthly Webinar #3 August 17 th & 19 th, 2015 Theresa Hoeft, PhD Ashley Heald, MA 2 Agenda Patient Consents Psychiatric Consultant training expectations Overview of upcoming CMTS training

More information

Take a Course of Action.

Take a Course of Action. Take a Course of Action. When you choose RAPS Online University, you ll be on track to expand your regulatory knowledge and advance your career. Our comprehensive learning provides an immersive experience

More information

Training & Resources for Clinical Research Professionals

Training & Resources for Clinical Research Professionals a division of Cambridge Healthtech Institute Training & Resources for Clinical Research Professionals Course & Publications Catalog January July 2013 In-Person and Web-Based Training Courses, Customized

More information

Physician / Investigator. Over 40% of clinical trial data are entered into health record and EDC 1

Physician / Investigator. Over 40% of clinical trial data are entered into health record and EDC 1 EHR4CR AN INNOVATIVE PLATFORM AND BUSINESS MODEL ACDM Annual Conference, 9 Richard Perkins, eclinical Forum Electronic Health Records for Clinical Research 1 Industry-centric growth in ICT 57% of R&D investment

More information

John R. Kasich, Governor Tracy J. Plouck, Director

John R. Kasich, Governor Tracy J. Plouck, Director John R. Kasich, Governor Tracy J. Plouck, Director All Ohio March 24, 2017 Ohio Medicaid Behavioral Health Redesign Initiative The Redesign Initiative is an integral component of Ohio s comprehensive strategy

More information

Potential of the use of electronic patient information for clinical research in the pharmaceutical industry

Potential of the use of electronic patient information for clinical research in the pharmaceutical industry Potential of the use of electronic patient information for clinical research in the pharmaceutical industry The case of the EHR4CR project Mats Sundgren, AstraZeneca Coordinator 1 Outline Problem statement

More information

Pharmacopoeia Conference

Pharmacopoeia Conference PDA Europe Conference, Exhibition, Education The Parenteral Drug Association presents: Pharmacopoeia Conference Convergence, Harmonization & The Future Direction of Pharmacopoeias EXHIBITION & SPONSORSHIP

More information

The Journey to Meaningful Use: Where we were, where we are, and where we may be going

The Journey to Meaningful Use: Where we were, where we are, and where we may be going The Journey to Meaningful Use: Where we were, where we are, and where we may be going June 27, 2013 Matthew Stanford, WHA Louis Wenzlow, RWHC 1 Where have we been? When HIT Adop on Meaningful Use Adoption

More information

A National Role Delineation Study of the Pediatric Emergency Nurse. Executive Summary

A National Role Delineation Study of the Pediatric Emergency Nurse. Executive Summary A National Role Delineation Study of the Pediatric Emergency Nurse Executive Summary Conducted for the Board of Certification for Emergency Nursing Prepared by Lawrence J. Fabrey, PhD, Sr. Vice President,

More information

Hybrid Hyperbaric Introductory Course

Hybrid Hyperbaric Introductory Course Hybrid Hyperbaric Introductory Course Hyperbaric Medicine Principles & Practice 40 Hour On-Line Didactic Lectures On-Site Hands-on Practicum 6737 W. Washington St., #3265 West Allis, WI 53214 p. 414.269.5337

More information

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law

Sponsor Responsibilities. Roles and Responsibilities. EU Directives. UK Law EU Directives Pharmacovigilance Legislation, SOPs and Reporting Louise Boldy, Governance & Safety Manager David Martin, Pharmacovigilance Monitor EU Legislation 2001/20/EC 2005/28/EC EudraLex Vol 10 UK

More information

February 4, John-Paul M. Mario, ASID Affiliate Chair 2011-Present Dear Affiliates:

February 4, John-Paul M. Mario, ASID Affiliate Chair 2011-Present Dear Affiliates: February 4, 2014 Dear Affiliates: John-Paul M. Mario, ASID Affiliate Chair 2011-Present JohnPaulASID@gmail.com 941-228-9968 As we begin this new year I and the Affiliate Advisory Board are looking forward

More information

Produce Safety Educator s Monthly Call #16 April 6, PM EST Meeting Summary

Produce Safety Educator s Monthly Call #16 April 6, PM EST Meeting Summary Produce Safety Educator s Monthly Call #16 April 6, 2015 2 PM EST Meeting Summary Total Attendance: 42 Meeting recording available at: https://cornell.webex.com/cornell/lsr.php?rcid=50401409f7d739b4642d051833685f3a

More information

Beyond Cost and Utilization: Rethinking Evaluation Strategies for Complex Care Programs

Beyond Cost and Utilization: Rethinking Evaluation Strategies for Complex Care Programs Beyond Cost and Utilization: Rethinking Evaluation Strategies for Complex Care Programs April 9, 2-3:30 pm (ET) Made possible with support from Kaiser Permanente Community Health Housekeeping This event

More information

36 th Annual Meeting Preconference Workshop P4 Handout

36 th Annual Meeting Preconference Workshop P4 Handout 36 th Annual Meeting Preconference Workshop P4 Handout Clinical Trial Management in Multicenter Trials: Collaborating for Success Meet Our Team Dixie Ecklund, RN, MSN, MBA Associate Director, University

More information

Registries for Evaluating Patient Outcomes:

Registries for Evaluating Patient Outcomes: Registries for Evaluating Patient Outcomes: An Introduction to the User s Guide Michelle B. Leavy Managing Editor December 17, 2013 Copyright 2013 Quintiles Your Presenter Michelle Leavy, MPH Research

More information

AN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES

AN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES 1 AN OVERVIEW OF CLINICAL STUDY TASKS AND ACTIVITIES Key Clinical Study Tasks and Activities 2 Discussion of Key Tasks and Activities 3 Development of the Clinical Protocol and Study Materials 3 Qualification

More information

VCU Clinical Research Quality Assurance Assessment

VCU Clinical Research Quality Assurance Assessment VCU Clinical Research Quality Assurance Assessment Principal Investigator Protocol Title Protocol IRB Number Name of Person Completing Assessment Date Assessment was Completed The goal of this assessment

More information

Determining and Reporting Adverse Events vs. Product Complaints

Determining and Reporting Adverse Events vs. Product Complaints Determining and Reporting Adverse Events vs. Product Complaints Pharma Perspective: Jacqueline Grissinger Director, Office of Consumer Medical Safety Johnson & Johnson Medical Device Perspective: Lisa

More information

International Perspectives. Marjorie S. Greenberg, MA National Center for Health Statistics Centers for Disease Control and Prevention

International Perspectives. Marjorie S. Greenberg, MA National Center for Health Statistics Centers for Disease Control and Prevention This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

Vascular Surgery Academic Coordinating Center (VSACC) & Peripheral Vascular Core Lab (PVCL)

Vascular Surgery Academic Coordinating Center (VSACC) & Peripheral Vascular Core Lab (PVCL) Vascular Surgery Academic Coordinating Center (VSACC) & Peripheral Vascular Core Lab (PVCL) What are the VSACC and the PVCL? The Vascular Surgery Academic Coordinating Center (VSACC) is an academic research

More information

Intertek Health, Environmental & Regulatory Services

Intertek Health, Environmental & Regulatory Services Intertek Health, Environmental & Regulatory Services Vai dove Ti porta la Chimica Go where the markets for Chemicals are! Workshop Centro REACH - 3 rd December 2014 Turkey - a country moving towards Europe

More information

CMS Priorities, MACRA and The Quality Payment Program

CMS Priorities, MACRA and The Quality Payment Program CMS Priorities, MACRA and The Quality Payment Program Ashby Wolfe, MD, MPP, MPH Chief Medical Officer, Region IX Centers for Medicare and Medicaid Services Presentation on behalf of HSAG November 16, 2016

More information

EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS)

EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS) EUCERD RECOMMENDATIONS on RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS) 31 January 2013 1 EUCERD RECOMMENDATIONS ON RARE DISEASE EUROPEAN REFERENCE NETWORKS (RD ERNS) INTRODUCTION 1. BACKGROUND TO

More information

Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol

Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or the clinical trial protocol 1 2 31 January 2017 EMA/430909/2016 3 4 5 Guideline for the notification of serious breaches of Regulation (EU) No 536/2014 or Draft Adopted by GCP Inspectors Working Group (GCP IWG) 30 January 2017 Adopted

More information

2016 Nominating Committee. ICANN55 9 March 2016

2016 Nominating Committee. ICANN55 9 March 2016 2016 Nominating Committee ICANN55 9 March 2016 Agenda 1 2 3 Introduction Stéphane Van Gelder Chair, 2016 NomCom Key Leadership Positions to be filled How to APPLY 4 5 6 NomCom Selection Process and Timeline

More information

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Safety Reporting in CTIMPs and ATMPs SOP number: TM-003 SOP category: Trial Management Version number: 04 Version date:

More information

Current and future standardization issues in the e Health domain: Achieving interoperability. Executive Summary

Current and future standardization issues in the e Health domain: Achieving interoperability. Executive Summary Report from the CEN/ISSS e Health Standardization Focus Group Current and future standardization issues in the e Health domain: Achieving interoperability Executive Summary Final version 2005 03 01 This

More information

JAS WG Final Report Supporting Applicants from Developing Economies. September 2011 Presenters: Avri Doria; Alan Greenberg

JAS WG Final Report Supporting Applicants from Developing Economies. September 2011 Presenters: Avri Doria; Alan Greenberg JAS WG Final Report Supporting Applicants from Developing Economies September 2011 Presenters: Avri Doria; Alan Greenberg Agenda Terminology Clarification Why provide support? Activities timeline Final

More information

Delivering a quality CDISC compliant accelerated submission using an outsourced model Mei Dey, AstraZeneca (USA) Diane Peers, AstraZeneca (UK)

Delivering a quality CDISC compliant accelerated submission using an outsourced model Mei Dey, AstraZeneca (USA) Diane Peers, AstraZeneca (UK) PharmaSUG 2016 - Paper PO11 Delivering a quality CDISC compliant accelerated submission using an outsourced model Mei Dey, AstraZeneca (USA) Diane Peers, AstraZeneca (UK) ABSTRACT Pharmaceutical companies

More information

This is a full time post offered on a fixed-term basis until 31 August 2019.

This is a full time post offered on a fixed-term basis until 31 August 2019. Faculty of Medicine and Health Sciences Norwich Medical School CTU Trial Assistant REF: SC3019 This is a full time post offered on a fixed-term basis until 31 August 2019. The Post A Clinical Trial Assistant

More information

Investigator Initiated-Sponsored Research (IISR)

Investigator Initiated-Sponsored Research (IISR) Investigator Initiated-Sponsored Research (IISR) State of the Industry and the Need for Global Standards and Metrics Alexander Kostek and DeeAnn Tinjum Disclaimer The views and opinions expressed by the

More information

22 Days til MIPS Data Submission! Get Ready!

22 Days til MIPS Data Submission! Get Ready! Countdown to MIPS* Data Submission Webinar Series 22 Days til MIPS Data Submission! Get Ready! Christine Lalios Kuykendall, BS, RHIA, CPHQ, IM Health Informatics Specialist Health Services Advisory Group

More information

FINAL DOCUMENT. Global Harmonization Task Force

FINAL DOCUMENT. Global Harmonization Task Force GHTF/SG5/N5:2012 FINAL DOCUMENT Global Harmonization Task Force Title: Reportable Events During Pre-Market Clinical Investigations Authoring Group: Study Group 5 of the Global Harmonization Task Force

More information

Standard Operating Procedures

Standard Operating Procedures Clinical Monitoring and Site Verification Procedure Overview To define the standard procedures for preparation and documentation of site visits for clinical monitoring and spoke verification for any NETT

More information

Direct Patient ADR reporting system in Japan. Kazuhiko Mori, Chief Safety Officer Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Direct Patient ADR reporting system in Japan. Kazuhiko Mori, Chief Safety Officer Pharmaceuticals and Medical Devices Agency (PMDA), Japan Direct Patient ADR reporting system in Japan Kazuhiko Mori, Chief Safety Officer Pharmaceuticals and Medical Devices Agency (PMDA), Japan Disclaimer The views and opinions expressed in the following PowerPoint

More information

The Pain or the Gain?

The Pain or the Gain? The Pain or the Gain? Comprehensive Care Joint Replacement (CJR) Model DRG 469 (Major joint replacement with major complications) DRG 470 (Major joint without major complications or comorbidities) Actual

More information

International District Cooling & Heating Conference

International District Cooling & Heating Conference International District Cooling & Heating Conference Consumer tariffs and markets Accelerating Urban Energy Systems in the Asia Pacific Region Mikael Jakobsson Executive Director Asia Pacific Urban Energy

More information

Essential Documents It s Not Just a Binder!

Essential Documents It s Not Just a Binder! Essential Documents It s Not Just a Binder! Kelly Unsworth, MS, CCRC, CIP Director of Research Education & Training Office for Human Subject Protection SCORE June 5, 2014 But What percentage of 2014 (to

More information

PHMPapers.org The PHM Society s paper submission, review, and distribution portal Conference Submission Instructions for Authors

PHMPapers.org The PHM Society s paper submission, review, and distribution portal Conference Submission Instructions for Authors PHMPapers.org The PHM Society s paper submission, review, and distribution portal Conference Submission Instructions for Authors 1 Introduction Welcome to PHMPapers.org! The PHM Society is now using a

More information

COMMISSIONING SUPPORT PROGRAMME. Standard operating procedure

COMMISSIONING SUPPORT PROGRAMME. Standard operating procedure NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE COMMISSIONING SUPPORT PROGRAMME Standard operating procedure April 2018 1. Introduction The Commissioning Support Programme (CSP) at NICE supports the

More information

Comparative Effectiveness Research and Patient Centered Outcomes Research in Public Health Settings: Design, Analysis, and Funding Considerations

Comparative Effectiveness Research and Patient Centered Outcomes Research in Public Health Settings: Design, Analysis, and Funding Considerations University of Kentucky UKnowledge Health Management and Policy Presentations Health Management and Policy 12-7-2012 Comparative Effectiveness Research and Patient Centered Outcomes Research in Public Health

More information

Delivery time frame for the EU portal and EU database

Delivery time frame for the EU portal and EU database 17 December 2015 EMA/760345/2015 Endorsed Draft time frame presented to European Medicines Agency Management Board 01 October 2015 Draft timeframe presented to IT Directors and Member States during the

More information

POSTGRADUATE DIPLOMA/MSc IN PHARMACEUTICAL MEDICINE

POSTGRADUATE DIPLOMA/MSc IN PHARMACEUTICAL MEDICINE POSTGRADUATE DIPLOMA/MSc IN PHARMACEUTICAL MEDICINE 2018/2020 University of Dublin, Trinity College Index Introduction... 1 Aims... 1 Intended Participants... 1 Course Structure... 2 Course Content and

More information

European CRO Federation

European CRO Federation European CRO Federation The interface between Industry CRO and Clinical Trials Networks: Defining the Roles EMA, London, 22 March 2012 Dr. Martine Dehlinger-Kremer Vice President Global Regulatory Affairs,

More information

MIPS Advancing Care Information: Tips, Tools and Support Q&A from Live Webinar March 29, 2017

MIPS Advancing Care Information: Tips, Tools and Support Q&A from Live Webinar March 29, 2017 MIPS Advancing Care Information: Tips, Tools and Support Q&A from Live Webinar March 29, 2017 Below are questions that were submitted during the Quality Insights Advancing Care Information webinar on March

More information

Work plan for GCP Inspectors Working Group for 2018

Work plan for GCP Inspectors Working Group for 2018 22 March 2018 EMA/87812 /2018 Committees and Inspections Chairperson: Ana Rodriguez The activities outlined in the work plan for 2018 have been agreed in view of preparation for the Agency s relocation

More information

June OLTL Updates PANAC June Agenda. RAI Spotlight PENNSYLVANIA DEPARTMENT OF HUMAN SERVICES OFFICE OF LONG-TERM LIVING

June OLTL Updates PANAC June Agenda. RAI Spotlight PENNSYLVANIA DEPARTMENT OF HUMAN SERVICES OFFICE OF LONG-TERM LIVING PENNSYLVANIA DEPARTMENT OF HUMAN SERVICES OFFICE OF LONG-TERM LIVING OLTL Updates PANAC Ruth Anne Barnard, BSN, RN MDS/OBRA Coordinator for Nursing Facility Field Operations Catharine B. Petko, BSN, RN

More information

Standard Operating Procedure

Standard Operating Procedure Standard Operating Procedure SOP number: SOP full title: SOP-JRO-07-004 Recording, managing and reporting Adverse Events for Clinical Trials of Investigational Medicinal Products and trials of Advanced

More information

SPONSORSHIP PACKAGES ENERGY EFFICIENCY WATCH 3 PROJECT Status 09 December 2014

SPONSORSHIP PACKAGES ENERGY EFFICIENCY WATCH 3 PROJECT Status 09 December 2014 SPONSORSHIP PACKAGES ENERGY EFFICIENCY WATCH 3 PROJECT 2014-2017 Status 09 December 2014 EEW3 PROJECT DESCRIPTION... 1 WHO IS BEHIND THE PROJECT?... 2 BACKGROUND OF THE EEW3... 3 WHY SPONSOR?... 4 OVERVIEW

More information

St. James s Hospital Research Governance and Support Framework

St. James s Hospital Research Governance and Support Framework St. James s Hospital Research Governance and Support Framework 2017 2019 St. James s Hospital Research Governance & Support Framework 2017 2019 Table of Contents SECTION 1... 1 1.1 Introduction... 1 1.2

More information

Information & Publicity of structural funds: The challenge of conforming to I&P rules and the importance of web based tools

Information & Publicity of structural funds: The challenge of conforming to I&P rules and the importance of web based tools Information & Publicity of structural funds: The challenge of conforming to I&P rules and the importance of web based tools Angelika IOANNIDES Head of Programming & Communication Management Organisation

More information

OneCity Health Partner Webinar

OneCity Health Partner Webinar 1 OneCity Health Partner Webinar Past, Present, and Looking Ahead December 13, 2016 Today s Presenter 2 Richard Bernstock, Bronx Hub Executive Director Topics for Today s Webinar 3 OneCity Health Partner

More information

2018 Quality Award New Applicant Overview Webinar August 22 nd 2017

2018 Quality Award New Applicant Overview Webinar August 22 nd 2017 2018 Quality Award New Applicant Overview Webinar August 22 nd 2017 Urvi Patel, Director, Quality Improvement Erin Prendergast, MPH, Senior Manager, Quality Improvement What is the Quality Award Program?

More information

AWS SUMMITS LATAM 2016

AWS SUMMITS LATAM 2016 AWS SUMMITS LATAM 2016 Bogota April 6, 2016 Corferias Buenos Aires April 28, 2016 Darwin Santiago May 3, 2016 W Hotel Mexico City May 26 th 2016 Centro Banamex Lima September 28 th 2016 The Westin Re-invent

More information

Conformity Assessment Approaches and Best Practices NIST Public Workshop. Session 4: Conformity Assessment Case Study Personal Protective Technologies

Conformity Assessment Approaches and Best Practices NIST Public Workshop. Session 4: Conformity Assessment Case Study Personal Protective Technologies Conformity Assessment Approaches and Best Practices NIST Public Workshop Session 4: Conformity Assessment Case Study Personal Protective Technologies Maryann D Alessandro, Ph.D. Director, National Personal

More information

Encounter Data System

Encounter Data System System Industry February 2, 2012 1 Introduction Session Guidelines CMS Agenda o Testing Timeline o EDFES Certification Status Test Cases Review Reports o EDFES 277CA o EDPS MAO-002 Flat File and Formatted

More information

MAXIMUS Webinar Series

MAXIMUS Webinar Series MAXIMUS Webinar Series What the Provider Enrollment Rule Means Operationally for States and MCOs, Including Network Adequacy Continuing the Discussion on the CMS Rule for Medicaid & CHIP Managed Care June

More information

Experiences of using routinely collected medical data in a cardiovascular safety trial?

Experiences of using routinely collected medical data in a cardiovascular safety trial? Experiences of using routinely collected medical data in a cardiovascular safety trial? Ian Ford Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit Issues in clinical trials Study feasibility

More information

Latham & Watkins Corporate Department

Latham & Watkins Corporate Department Number 1133 January 27, 2011 Client Alert Latham & Watkins Corporate Department FDA Announces Actions Designed to Improve the 510(k) Premarket Clearance Process Importantly, however, the Agency s identified

More information

Co-operative Agreement for Research Ethics Review between NHG DSRB and NTU IRB

Co-operative Agreement for Research Ethics Review between NHG DSRB and NTU IRB Co-operative Agreement for Research Ethics Review between NHG DSRB and NTU IRB Frequently Asked Questions 1. What type of collaborative studies is eligible for single IRB reviews? All new collaborative

More information

A Dedicated Post Authorisation Measure Submission Form

A Dedicated Post Authorisation Measure Submission Form A Dedicated Post Authorisation Measure Submission Form An improved way of submitting your PAM to the EMA Presented by Hector Boix Perales on 03 July 2017 Procedure Management Department Human Medicines

More information

U.S. Chamber of Commerce 1615 H Street NW Washington, DC INTERNSHIP PROGAM

U.S. Chamber of Commerce 1615 H Street NW Washington, DC INTERNSHIP PROGAM U.S. Chamber of Commerce 1615 H Street NW Washington, DC 20062 INTERNSHIP PROGAM Summer 2017 Internship Opportunities Communications Title: Communications & Strategy Intern Department Description: The

More information

IPRO ESRD Network of the South Atlantic HAI BSI/LTC QIA 2018 Kickoff Webinar

IPRO ESRD Network of the South Atlantic HAI BSI/LTC QIA 2018 Kickoff Webinar IPRO ESRD Network of the South Atlantic HAI BSI/LTC QIA 2018 Kickoff Webinar February 7, 2018 Welcome/Opening Remarks Jeanine Pilgrim, Quality Improvement Director Housekeeping Reminders All phone lines

More information

CDISC 2012 Annual Report TEAMWORK.... with collaboration there is strength.

CDISC 2012 Annual Report TEAMWORK.... with collaboration there is strength. CDISC 2012 Annual Report TEAMWORK... with collaboration there is strength. President s Letter Unity is strength when there is teamwork and collaboration, wonderful things can be achieved. Mattie Stepanek,

More information

Measures of impact of pharmacovigilance processes (3.3)

Measures of impact of pharmacovigilance processes (3.3) Measures of impact of pharmacovigilance processes (3.3) Session 4 - Reports from breakout sessions: gaps and observations Workshop: Measuring the Impact of Pharmacovigilance Activities London, 5-6 December

More information